Autopsy report · NCT02974140

Cataract Refractive Suite Study

“Management Decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 5 months before it stopped.
• 39 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Alcon, a Novartis Company

Sponsor type

Industry

Conditions

Cataracts

Interventions

Cataract Refractive Suite (CRS); Standard manual technique

Participants

39

Sites

3

Countries

United States

Trials that died the same way

• ActaVisc and ActaVisc Mx Intra-articular Injection for Pain Associated With Osteoarthritis in the Knee
  “Business decision” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.